Hand osteoarthritis: New insights

Joint Bone Spine

Volumn 80, Issue 2, 2013, Pages 130-134

  Gabay, Odile ^a   Gabay, Cem ^b  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Biology; Genetic; Hand OA

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CAPSAICIN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; ECTONUCLEOTIDE PYROPHOSPHATASE 1; ESTROGEN RECEPTOR BETA; HYALURONIC ACID; INORGANIC PYROPHOSPHATASE; KLOTHO PROTEIN; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RESISTIN; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ALTERNATIVE MEDICINE; AUTOIMMUNE THYROIDITIS; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CARDIOVASCULAR MORTALITY; CAROTID ATHEROSCLEROSIS; CHROMOSOME 6; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EXERCISE; GENETIC ASSOCIATION; GLOVE; HAND OSTEOARTHRITIS; HANDEDNESS; HEALTH EDUCATION; HERBAL MEDICINE; HIP OSTEOARTHRITIS; HUMAN; HYPERCHOLESTEROLEMIA; KNEE OSTEOARTHRITIS; LOW LEVEL LASER THERAPY; NUTRITIONAL COUNSELING; OBESITY; OCCUPATION; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SEX DIFFERENCE; SHORT SURVEY; SPLINT; TRANSCUTANEOUS NERVE STIMULATION; YOGA;

ANTIRHEUMATIC AGENTS; HAND; HUMANS; OSTEOARTHRITIS;

EID: 84875545992     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.06.011     Document Type: Short Survey

References (59)

1. Pereira D., Peleteiro B., Araujo J., et al. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage 2011, 19:1270-1285.
2. Kalichman L., Cohen Z., Kobyliansky E., et al. Patterns of joint distribution in hand osteoarthritis: contribution of age, sex, and handedness. Am J Hum Biol 2004, 16:125-134.
3. Kwok W.Y., Vliet Vlieland T.P., Rosendaal F.R., et al. Limitations in daily activities are the major determinant of reduced health-related quality of life in patients with hand osteoarthritis. Ann Rheum Dis 2011, 70:334-336.
4. Altman R., Alarcon G., Appelrouth D., et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990, 33:1601-1610.
5. Haugen I.K., Lillegraven S., Slatkowsky-Christensen B., et al. Hand osteoarthritis and MRI: development and first validation step of the proposed Oslo Hand Osteoarthritis MRI score. Ann Rheum Dis 2011, 70:1033-1038.
6. Addimanda O., Mancarella L., Dolzani P., et al. Clinical associations in patients with hand osteoarthritis. Scand J Rheumatol 2012.
7. Rees F., Doherty S., Hui M., et al. Distribution of finger nodes and their association with underlying radiographic features of osteoarthritis. Arthritis Care Res (Hoboken) 2012, 64:533-538.
8. Punzi L., Ramonda R., Deberg M., et al. Coll2-1, Coll2-1NO2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands. Osteoarthritis Cartilage 2012, 20:557-561. [Epub 2012 Mar 5].
9. Filkova M., Senolt L., Braun M., et al. Serum hyaluronic acid as a potential marker with a predictive value for further radiographic progression of hand osteoarthritis. Osteoarthritis Cartilage 2009, 17:1615-1619.
10. Zhang Y., Niu J., Kelly-Hayes M., et al. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: The Framingham Study. Am J Epidemiol 2002, 156:1021-1027.
11. Carmona L., Ballina J., Gabriel R., et al. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 2001, 60:1040-1045.
12. Goekoop R.J., Kloppenburg M., Kroon H.M., et al. Determinants of absence of osteoarthritis in old age. Scand J Rheumatol 2011, 40:68-73.
13. Hochberg M.C., Lethbridge-Cejku M., Scott W.W., et al. Obesity and osteoarthritis of the hands in women. Osteoarthritis Cartilage 1993, 1:129-135.
14. Denisov L.N., Nasonova V.A., Koreshkov G.G., et al. Role of obesity in the development of osteoarthrosis and concomitant diseases. Ter Arkh 2011, 82:34-37.
15. Cicuttini F.M., Baker J.R., Spector T.D. The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 1996, 23:1221-1226.
16. Sayer A.A., Poole J., Cox V., et al. Weight from birth to 53 years: a longitudinal study of the influence on clinical hand osteoarthritis. Arthritis Rheum 2003, 48:1030-1033.
17. Grotle M., Hagen K.B., Natvig B., et al. Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord 2008, 9:132.
18. Killock D. Osteoarthritis: the influence of obesity on OA-does size matter or is metabolic dysfunction more important?. Nat Rev Rheumatol 2011, 8:61.
19. Magliano M., Obesity arthritis. Menopause Int 2008, 14:149-154.
20. Gabay O.B.F. Adipokines in arthritis: new kids on the block. Curr Rheumatol Rev 2009, 5:226-232.
21. Dumond H., Presle N., Terlain B., et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 2003, 48:3118-3129.
22. Griffin T.M., Huebner J.L., Kraus V.B., et al. Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis. Arthritis Rheum 2009, 60:2935-2944.
23. Teichtahl A.J., Wluka A.E., Proietto J., et al. Obesity and the female sex, risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. Med Hypotheses 2005, 65:312-315.
24. Wislowska M., Rok M., Jaszczyk B., et al. Serum leptin in rheumatoid arthritis. Rheumatol Int 2007, 27:947-954.
25. Lubbeke A., Garavaglia G., Barea C., et al. Influence of patient activity on femoral osteolysis at five and ten years following hybrid total hip replacement. J Bone Joint Surg Br 2011, 93:456-463.
26. Yammani R.R., Loeser R.F. Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes. Arthritis Res Ther 2012, 14:R23.
27. Gegout P.P., Francin P.J., Mainard D., et al. Adipokines in osteoarthritis: friends or foes of cartilage homeostasis?. Joint Bone Spine 2008, 75:669-671.
28. Bokarewa M., Nagaev I., Dahlberg L., et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005, 174:5789-5795.
29. Choe J.Y., Bae J., Jung H.Y., et al. Serum resistin level is associated with radiographic changes in hand osteoarthritis: cross-sectional study. Joint Bone Spine 2011, 79:160-165.
30. Berry P.A., Jones S.W., Cicuttini F.M., et al. Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritis. Arthritis Rheum 2011, 63:700-707.
31. Rai M.F., Sandell L.J. Inflammatory mediators: tracing links between obesity and osteoarthritis. Crit Rev Eukaryot Gene Expr 2011, 21:131-142.
32. Bonet M.L., Granados N., Palou A. Molecular players at the intersection of obesity and osteoarthritis. Curr Drug Targets 2011, 12:2103-2128.
33. Felson D.T. Risk factors for osteoarthritis: understanding joint vulnerability. Clin Orthop Relat Res 2004, S16-S21. Review.
34. Spector T.D., Cicuttini F., Baker J., et al. Genetic influences on osteoarthritis in women: a twin study. BMJ 1996, 312:940-943.
35. Jakowlev K., Livshits G., Kalichman L., et al. Search for hand osteoarthritis susceptibility locus on chromosome 6p12.3-p12.1. Hum Biol 2007, 79:1-14.
36. Suk E.K., Malkin I., Dahm S., et al. Association of ENPP1 gene polymorphisms with hand osteoarthritis in a Chuvasha population. Arthritis Res Ther 2005, 7:R1082-R1090.
37. Livshits G. Genetic epidemiology of skeletal system aging in apparently healthy human population. Mech Ageing Dev 2005, 126:269-279.
38. Zhang F., Zhai G., Kato B.S., et al. Association between KLOTHO gene and hand osteoarthritis in a female Caucasian population. Osteoarthritis Cartilage 2007, 15:624-629.
39. Kerkhof H.J., Meulenbelt I., Carr A., et al. Common genetic variation in the Estrogen Receptor Beta (ESR2) gene and osteoarthritis: results of a meta-analysis. BMC Med Genet 2012, 11:164.
40. Evangelou E., Chapman K., Meulenbelt I., et al. Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum 2009, 60:1710-1721.
41. Nakki A., Kouhia S.T., Saarela J., et al. Allelic variants of IL1R1 gene associate with severe hand osteoarthritis. BMC Med Genet 2011, 11:50.
42. Kamarainen O.P., Solovieva S., Vehmas T., et al. Aggrecan core protein of a certain length is protective against hand osteoarthritis. Osteoarthritis Cartilage 2006, 14:1075-1080.
43. Dahaghin S., Bierma-Zeinstra S.M., Reijman M., et al. Does hand osteoarthritis predict future hip or knee osteoarthritis?. Arthritis Rheum 2005, 52:3520-3527.
44. Jonsson H., Helgadottir G.P., Aspelund T., et al. Hand osteoarthritis severity is associated with total knee joint replacements independently of BMI. The Ages-Reykjavik Study. Open Rheumatol J 2011, 5:7-12.
45. Valdes A.M., McWilliams D., Arden N.K., et al. Involvement of different risk factors in clinically severe large joint osteoarthritis according to the presence of hand interphalangeal nodes. Arthritis Rheum 2011, 62:2688-2695.
46. Haugen I.K., Cotofana S., Englund M., et al. Hand joint space narrowing and osteophytes are associated with magnetic resonance imaging-defined knee cartilage thickness and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative. J Rheumatol 2011, 39:161-166.
47. Hill S., Dziedzic K.S., Nio Ong B. Patients' perceptions of the treatment and management of hand osteoarthritis: a focus group enquiry. Disabil Rehabil 2011, 33:1866-1872.
48. Mahendira D., Towheed T.E. Systematic review of non-surgical therapies for osteoarthritis of the hand: an update. Osteoarthritis Cartilage 2009, 17:1263-1268.
49. Zhang W., Doherty M., Leeb B.F., et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007, 66:377-388.
50. Baraf H.S., Gold M.S., Petruschke R.A., et al. Tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Am J Geriatr Pharmacother 2011, 10:47-60.
51. Gabay C., Medinger-Sadowski C., Gascon D., et al. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center. Arthritis Rheum 2011, 63:3383-3391.
52. Radics N.D.L., Falaus S. Methotrexate in erosive hand osteoarthritis. Ann Rheum Dis 2008, 67:2.
53. Bryant L.R., des Rosier K.F., Carpenter M.T. Hydroxychloroquine in the treatment of erosive osteoarthritis. J Rheumatol 1995, 22:1527-1531.
54. Fioravanti A., Fabbroni M., Cerase A., et al. Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot study. Rheumatol Int 2009, 29:961-965.
55. Magnano M.D., Chakravarty E.F., Broudy C., et al. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. J Rheumatol 2007, 34:1323-1327.
56. Verbruggen G., Wittoek R., Cruyssen B.V., et al. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis 2012, 71:891-898. [Epub 2011 Nov 29].
57. Baconnier L.J.C., Fabre S. Erosive osteoarthritis of the hand: clinical experience with anakinra. Ann Rheum Dis 2009, 68:1078-1079.
58. Bliddal H., Leeds A.R., Stigsgaard L., et al. Weight loss as treatment for knee osteoarthritis symptoms in obese patients: 1-year results from a randomised controlled trial. Ann Rheum Dis 2011, 70:1798-1803. [Epub 2011 Aug 5].
59. Richette P., Poitou C., Garnero P., et al. Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Ann Rheum Dis 2011, 70:139-144.